About SYNLAB AG

Company Description

SYNLAB offers a full range of medical diagnostic services for practising doctors, clinics and patients.
The SYNLAB Group is the uncontested leader on the European market for human medicine laboratory services. SYNLAB particularly focuses on the implementation of innovative laboratory medicine methods and on networking specialist diagnostic competences (SYNLAB Centres of Excellence).

SYNLAB maintains additional laboratories (strategic business units) in individual countries for veterinary medicine. This services portfolio is rounded off by expert medical imaging centres, day clinics and ambulatory services in certain countries.

The group works closely with research institutions and universities and also maintains an educational institution of its own, the SYNLAB Academy.

Year founded

2010

Served area

Worldwide

Headcount

30,570

Headquarters

Moosacher Straße 88, 80809 München – Germany

Publications

Insider Trades

Date Trading entity / Person Association Trade type Volume Average price
10.05.22 Henkel, Dr. Holger Supervisory board Other 0.00 € 10.05.22
04.05.22 Riedel, Oliver Board Buy 5,800.00 € 04.05.22
02.05.22 Schmitt, Martin Supervisory board Buy 1,071.00 € 02.05.22
21.12.21 Lorenz-Meyer, Robert Supervisory board Sell 8,960.90 € 21.12.21

Shareholder information

Shares outstanding

222,222,000

IPO

April 30, 2021

Designated Sponsor(s)

Goldman Sachs Bank Europe SE, J. P. Morgan AG

Stock exchange(s)

Frankfurt Stock Exchange

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.